Back

Atrial fibrillation and in-hospital mortality in Covid-19 patients

16 April 2023 (09:10 - 09:20)
Organised by:
Congress Presentation Part of: Atrial Fibrillation - Round 1 - Drugs, Prevention Prevalence and Incidence of Atrial Fibrillation EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Irum Kotadia

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study
Doctor S. Diederichsen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation is an independent risk factor for heart failure progression and pump failure mortality in HFpEF:: a propensity score matched analysis of the TOPCAT Americas study
Professor D. Shah (Geneva, CH)
Abstract Slides Video
Presentation thumbnail
Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)
Doctor S. Simovic (Kragujevac, RS)
Abstract Slides Video
Presentation thumbnail
Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus
Doctor H. Ahn (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation
Doctor R. Wijesurendra (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial Fibrillation - Round 1 - Drugs, Prevention
Video

The Event

Event poster

EHRA 2023

16 April 2023 09:10 CET
You may be interested in
thumbnail
Congress Presentation
Impact of atrial fibrillation on mortality and non-fatal cardiovascular outcomes in 145 293 patients admitted with COVID-19: a statewide population-linkage study
thumbnail
Congress Presentation
Predictors of new-onset in-hospital atrial fibrillation in 122 089 patients admitted with COVID-19: an Australian statewide population study
thumbnail
Congress Presentation
Permanent and persistent atrial fibrillation are independent risk factors of mortality after severe COVID-19

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources